Clarivate Plc has released the Top 100 Global Innovators™ 2022 list. Drawing on Clarivate™ data, the annual list identifies the organizations that demonstrate consistent, above-the-bar innovation excellence and which sit at the very top of the global innovation ecosystem.
As it relates to pharma and medtech, three companies in those industries have been identified in this year’s top 100 list, including:
The pharmaceuticals sector remains represented in the Top 100 Global Innovators 2022, but perhaps at a lower level than in previous years. This sector’s success in delivering vast improvement in human health, highlighted so importantly during the last 2 years, is partially due to the very high level of collaboration and partnership the sector has evolved into over the past two decades.
Read more about the full report here.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.